| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Spam Blocker > The Cybermagic of Whitelists |
|
Main Subject - The Cybermagic of Whitelists
Before we start getting deep into the meat of this article it's important to explain some standard te According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rminology to make sure the rest of this article makes sense.
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in h identifies your location on the Internet. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. spam software uses to block incoming spam. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe l> A whitelist is a predefined list of IP addresses that are allowed to send email to and receive em d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ail from each other. Blacklists exclude known and suspected spammers. Whitelists can be used to exclu ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e everyone except known IP addresses. Think of it like this. A whitelist is a like having a phonebook easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi which is owned by a small group of people who only wish to speak directly to each other. They don't w nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nt just anybody ringing them. Not only that but the entire group need to approve new phone numbers be and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ fore they appear in this exclusive phonebook. To send email to a whitelist you must be approved by t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e owner of the whitelist. This is a lot like the double optin systems used by legimiate ezines and ma ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ling list owners. Whitelists are the nightclub bouncers of the virtual world - if you ain't on the li dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t you ain't getting in. Simple but very effective. A real world example of a whitelist would be if t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin wo companies wanted to exchange email only with each other. These companies could implement a whiteli tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t that contained the IP address for just the two email servers that want to send email to each other. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel That would mean that any email coming from an IP address not on the whitelist would be returned to se ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust der. For companies they can ensure that employees are only dealing with work related email and not ch y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products atting with their friends. The benefits of whitelists are many but proper management of the whitelis . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s is equally important. Misuse of whitelists will only lead to more headaches for everyone involved w elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip th missing email, irate customers and IT departments doing overtime just being the tip of the iceberg tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Start Spreading the News! Nursing Jobs in New York How To Successfully Market Your Web Site
|